Johanne U. Hermansen

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia.

Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia.

Journal: British journal of haematology

Published: February 13, 2026

Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.

Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.

Journal: Cell death & disease

Published: September 02, 2024

Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery.

Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery.

Journal: NPJ precision oncology

Published: November 03, 2023

Standardized assays to monitor drug sensitivity in hematologic cancers.

Standardized assays to monitor drug sensitivity in hematologic cancers.

Journal: Cell death discovery

Published: July 13, 2023

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Journal: Nature communications

Published: June 19, 2023

Reduced abundance of Faecalibacterium prausnitzii in the gut microbiota of children diagnosed with cancer, a pilot study.

Reduced abundance of Faecalibacterium prausnitzii in the gut microbiota of children diagnosed with cancer, a pilot study.

Journal: Frontiers in microbiomes

Published: January 26, 2023

A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine.

A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine.

Journal: Cell death discovery

Published: November 21, 2022

Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A.

Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A.

Journal: Journal of hepatology

Published: May 25, 2022

The Norwegian childhood cancer biobank.

The Norwegian childhood cancer biobank.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 12, 2021

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.

Journal: Lancet (London, England)

Published: September 05, 2019

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL.

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL.

Journal: Leukemia

Published: February 21, 2019

Cryopreservation of primary B cells minimally influences their signaling responses.

Cryopreservation of primary B cells minimally influences their signaling responses.

Journal: Scientific reports

Published: August 07, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026